Morphine for the Treatment of Pain in Sickle Cell Disease
Pain is a hallmark of sickle cell disease (SCD) and its treatment remains challenging. Opioids are the major family of analgesics that are commonly used for treating severe pain. However, these are not always effective and are associated with the liabilities of their own. The pharmacology and multio...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1155/2015/540154 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552260401364992 |
|---|---|
| author | Mihir Gupta Lilian Msambichaka Samir K. Ballas Kalpna Gupta |
| author_facet | Mihir Gupta Lilian Msambichaka Samir K. Ballas Kalpna Gupta |
| author_sort | Mihir Gupta |
| collection | DOAJ |
| description | Pain is a hallmark of sickle cell disease (SCD) and its treatment remains challenging. Opioids are the major family of analgesics that are commonly used for treating severe pain. However, these are not always effective and are associated with the liabilities of their own. The pharmacology and multiorgan side effects of opioids are rapidly emerging areas of investigation, but there remains a scarcity of clinical studies. Due to opioid-induced endothelial-, mast cell-, renal mesangial-, and epithelial-cell-specific effects and proinflammatory as well as growth influencing signaling, it is likely that when used for analgesia, opioids may have organ specific pathological effects. Experimental and clinical studies, even though extremely few, suggest that opioids may exacerbate existent organ damage and also stimulate pathologies of their own. Because of the recurrent and/or chronic use of large doses of opioids in SCD, it is critical to evaluate the role and contribution of opioids in many complications of SCD. The aim of this review is to initiate inquiry to develop strategies that may prevent the inadvertent effect of opioids on organ function in SCD, should it occur, without compromising analgesia. |
| format | Article |
| id | doaj-art-d1bc4de728324171a95209fdacd4120f |
| institution | Kabale University |
| issn | 2356-6140 1537-744X |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | The Scientific World Journal |
| spelling | doaj-art-d1bc4de728324171a95209fdacd4120f2025-02-03T05:59:14ZengWileyThe Scientific World Journal2356-61401537-744X2015-01-01201510.1155/2015/540154540154Morphine for the Treatment of Pain in Sickle Cell DiseaseMihir Gupta0Lilian Msambichaka1Samir K. Ballas2Kalpna Gupta3Stanford University School of Medicine, Stanford, CA 94305, USAVascular Biology Center, Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Mayo Mail Code 480, 420 Delaware Street SE, Minneapolis, MN 55455, USACardeza Foundation for Hematologic Research, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USAVascular Biology Center, Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical School, Mayo Mail Code 480, 420 Delaware Street SE, Minneapolis, MN 55455, USAPain is a hallmark of sickle cell disease (SCD) and its treatment remains challenging. Opioids are the major family of analgesics that are commonly used for treating severe pain. However, these are not always effective and are associated with the liabilities of their own. The pharmacology and multiorgan side effects of opioids are rapidly emerging areas of investigation, but there remains a scarcity of clinical studies. Due to opioid-induced endothelial-, mast cell-, renal mesangial-, and epithelial-cell-specific effects and proinflammatory as well as growth influencing signaling, it is likely that when used for analgesia, opioids may have organ specific pathological effects. Experimental and clinical studies, even though extremely few, suggest that opioids may exacerbate existent organ damage and also stimulate pathologies of their own. Because of the recurrent and/or chronic use of large doses of opioids in SCD, it is critical to evaluate the role and contribution of opioids in many complications of SCD. The aim of this review is to initiate inquiry to develop strategies that may prevent the inadvertent effect of opioids on organ function in SCD, should it occur, without compromising analgesia.http://dx.doi.org/10.1155/2015/540154 |
| spellingShingle | Mihir Gupta Lilian Msambichaka Samir K. Ballas Kalpna Gupta Morphine for the Treatment of Pain in Sickle Cell Disease The Scientific World Journal |
| title | Morphine for the Treatment of Pain in Sickle Cell Disease |
| title_full | Morphine for the Treatment of Pain in Sickle Cell Disease |
| title_fullStr | Morphine for the Treatment of Pain in Sickle Cell Disease |
| title_full_unstemmed | Morphine for the Treatment of Pain in Sickle Cell Disease |
| title_short | Morphine for the Treatment of Pain in Sickle Cell Disease |
| title_sort | morphine for the treatment of pain in sickle cell disease |
| url | http://dx.doi.org/10.1155/2015/540154 |
| work_keys_str_mv | AT mihirgupta morphineforthetreatmentofpaininsicklecelldisease AT lilianmsambichaka morphineforthetreatmentofpaininsicklecelldisease AT samirkballas morphineforthetreatmentofpaininsicklecelldisease AT kalpnagupta morphineforthetreatmentofpaininsicklecelldisease |